UK markets closed

Anthem, Inc. (0HG8.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
437.84+3.81 (+0.88%)
At close: 04:23PM GMT
Full screen
Previous close434.03
Bid0.00 x 0
Ask0.00 x 0
Day's range437.57 - 439.77
52-week range437.57 - 439.77
Avg. volumeN/A
Market cap113.146B
Beta (5Y monthly)N/A
PE ratio (TTM)17.70
EPS (TTM)24.73
Earnings date19 Apr 2022 - 25 Apr 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Zacks

    Anthem's (ANTM) Q4 Earnings Beat Estimates, Improve Y/Y

    Anthem's (ANTM) Q4 results reflect better revenues and a solid contribution from its Government Business and IngenioRx businesses, partly offset by escalating expenses.

  • Zacks

    Anthem (ANTM) Q4 Earnings Top Estimates

    Anthem (ANTM) delivered earnings and revenue surprises of 0.59% and 0.91%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

  • Reuters

    Anthem warns of elevated COVID costs in first quarter on Omicron surge

    (Reuters) -U.S. health insurer Anthem Inc on Wednesday issued a conservative annual profit forecast and warned that the highly contagious Omicron variant was likely to drive up treatment, vaccination and testing costs in the first quarter. Since the start of the pandemic, profits of health insurers have come under pressure as huge costs related to direct COVID-19 treatment and tests cancel out any advantage gained from lower expenses due to delays in elective procedures. "We anticipate another year in which the overall cost of care will track above normalized levels driven by COVID-related treatment, vaccination and testing costs," Chief Financial Officer John Gallina said.